The availability of insulin pumps communicating with CGM sensors has stimulated the development of algorithms for the automatic suspension or attenuation of basal insulin delivery when hypoglycemia is either detected or predicted from CGM readings. This evidence concerns the gene INS and Hypoglycemia.